JP6941052B2 - 発毛を調節するための方法および組成物 - Google Patents
発毛を調節するための方法および組成物 Download PDFInfo
- Publication number
- JP6941052B2 JP6941052B2 JP2017500319A JP2017500319A JP6941052B2 JP 6941052 B2 JP6941052 B2 JP 6941052B2 JP 2017500319 A JP2017500319 A JP 2017500319A JP 2017500319 A JP2017500319 A JP 2017500319A JP 6941052 B2 JP6941052 B2 JP 6941052B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- population
- induced
- hipsc
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 101
- 230000003779 hair growth Effects 0.000 title claims description 32
- 239000000203 mixture Substances 0.000 title claims description 30
- 230000001105 regulatory effect Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 claims description 264
- 210000004209 hair Anatomy 0.000 claims description 85
- 230000002500 effect on skin Effects 0.000 claims description 66
- 210000001982 neural crest cell Anatomy 0.000 claims description 47
- 210000000130 stem cell Anatomy 0.000 claims description 41
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 40
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 40
- 210000003491 skin Anatomy 0.000 claims description 40
- 102000008730 Nestin Human genes 0.000 claims description 37
- 108010088225 Nestin Proteins 0.000 claims description 37
- 210000005055 nestin Anatomy 0.000 claims description 37
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 32
- 230000001939 inductive effect Effects 0.000 claims description 31
- 210000004927 skin cell Anatomy 0.000 claims description 29
- 230000000694 effects Effects 0.000 claims description 28
- 230000001464 adherent effect Effects 0.000 claims description 24
- 210000001519 tissue Anatomy 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 23
- 239000000543 intermediate Substances 0.000 claims description 22
- 210000002950 fibroblast Anatomy 0.000 claims description 21
- 239000003550 marker Substances 0.000 claims description 21
- 210000002460 smooth muscle Anatomy 0.000 claims description 21
- 108010067306 Fibronectins Proteins 0.000 claims description 20
- 102000007469 Actins Human genes 0.000 claims description 19
- 108010085238 Actins Proteins 0.000 claims description 19
- 238000012258 culturing Methods 0.000 claims description 19
- 238000012360 testing method Methods 0.000 claims description 18
- 102000013127 Vimentin Human genes 0.000 claims description 16
- 108010065472 Vimentin Proteins 0.000 claims description 16
- 101150075618 foxd3 gene Proteins 0.000 claims description 16
- 101150077014 sox10 gene Proteins 0.000 claims description 16
- 210000005048 vimentin Anatomy 0.000 claims description 16
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims description 14
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 14
- 230000006698 induction Effects 0.000 claims description 13
- 210000004761 scalp Anatomy 0.000 claims description 12
- 102100032912 CD44 antigen Human genes 0.000 claims description 11
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 11
- 108010055896 polyornithine Proteins 0.000 claims description 11
- 201000004384 Alopecia Diseases 0.000 claims description 10
- 210000004709 eyebrow Anatomy 0.000 claims description 10
- 229920002714 polyornithine Polymers 0.000 claims description 10
- 238000007920 subcutaneous administration Methods 0.000 claims description 10
- -1 C D184 Proteins 0.000 claims description 9
- 210000000601 blood cell Anatomy 0.000 claims description 9
- 108020003175 receptors Proteins 0.000 claims description 9
- 210000001015 abdomen Anatomy 0.000 claims description 8
- 210000002919 epithelial cell Anatomy 0.000 claims description 8
- 229920003023 plastic Polymers 0.000 claims description 8
- 210000000617 arm Anatomy 0.000 claims description 7
- 210000002414 leg Anatomy 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 231100000360 alopecia Toxicity 0.000 claims description 6
- 231100000241 scar Toxicity 0.000 claims description 5
- 230000003676 hair loss Effects 0.000 claims description 4
- 238000007747 plating Methods 0.000 claims description 4
- 208000024963 hair loss Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 102100037362 Fibronectin Human genes 0.000 claims 5
- 230000001537 neural effect Effects 0.000 claims 3
- 239000000853 adhesive Substances 0.000 claims 2
- 230000001070 adhesive effect Effects 0.000 claims 2
- 210000000088 lip Anatomy 0.000 claims 2
- 210000004013 groin Anatomy 0.000 claims 1
- 210000001985 kidney epithelial cell Anatomy 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 210000000933 neural crest Anatomy 0.000 description 46
- 230000014509 gene expression Effects 0.000 description 42
- 210000003317 double-positive, alpha-beta immature T lymphocyte Anatomy 0.000 description 38
- 210000003780 hair follicle Anatomy 0.000 description 28
- 238000002054 transplantation Methods 0.000 description 24
- 241000699666 Mus <mouse, genus> Species 0.000 description 22
- 230000015572 biosynthetic process Effects 0.000 description 19
- 230000004069 differentiation Effects 0.000 description 18
- 102000009389 Prostaglandin D receptors Human genes 0.000 description 17
- 108050000258 Prostaglandin D receptors Proteins 0.000 description 17
- 238000001000 micrograph Methods 0.000 description 17
- 102100032818 Integrin alpha-4 Human genes 0.000 description 16
- 108010041012 Integrin alpha4 Proteins 0.000 description 16
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 15
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 15
- 102000016359 Fibronectins Human genes 0.000 description 15
- 238000001190 Q-PCR Methods 0.000 description 15
- 229940112869 bone morphogenetic protein Drugs 0.000 description 15
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 14
- 238000003125 immunofluorescent labeling Methods 0.000 description 13
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 210000004919 hair shaft Anatomy 0.000 description 12
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 11
- 210000002510 keratinocyte Anatomy 0.000 description 11
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 10
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 10
- 238000004624 confocal microscopy Methods 0.000 description 10
- 239000002775 capsule Substances 0.000 description 9
- 238000004113 cell culture Methods 0.000 description 9
- 210000001671 embryonic stem cell Anatomy 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 241000699660 Mus musculus Species 0.000 description 8
- 238000011580 nude mouse model Methods 0.000 description 8
- 102000005962 receptors Human genes 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 7
- 101150106167 SOX9 gene Proteins 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 210000001339 epidermal cell Anatomy 0.000 description 7
- 230000011664 signaling Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 210000004207 dermis Anatomy 0.000 description 6
- 210000000720 eyelash Anatomy 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000003716 mesoderm Anatomy 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000006628 dp medium Substances 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 230000001617 migratory effect Effects 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 210000004918 root sheath Anatomy 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000003662 hair growth rate Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 3
- 101000883443 Mus musculus Desmoplakin Proteins 0.000 description 3
- 235000013290 Sagittaria latifolia Nutrition 0.000 description 3
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000015246 common arrowhead Nutrition 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000003101 melanogenic effect Effects 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- 238000000059 patterning Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 101150038679 skp gene Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 2
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 108010007093 dispase Proteins 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 108700007229 noggin Proteins 0.000 description 2
- 102000045246 noggin Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 210000001778 pluripotent stem cell Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 230000002992 thymic effect Effects 0.000 description 2
- 210000003135 vibrissae Anatomy 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 102100037293 Atrial natriuretic peptide-converting enzyme Human genes 0.000 description 1
- 101710133555 Atrial natriuretic peptide-converting enzyme Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 1
- 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 102000013814 Wnt Human genes 0.000 description 1
- 108010076089 accutase Proteins 0.000 description 1
- 210000001943 adrenal medulla Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- XHBVYDAKJHETMP-UHFFFAOYSA-N dorsomorphin Chemical compound C=1C=C(C2=CN3N=CC(=C3N=C2)C=2C=CN=CC=2)C=CC=1OCCN1CCCCC1 XHBVYDAKJHETMP-UHFFFAOYSA-N 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002514 epidermal stem cell Anatomy 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 230000003784 hair-inductive capacity Effects 0.000 description 1
- 238000013388 immunohistochemistry analysis Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 210000001208 inner root sheath cell Anatomy 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0627—Hair cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021082226A JP2021119202A (ja) | 2014-07-09 | 2021-05-14 | 発毛を調節するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462022639P | 2014-07-09 | 2014-07-09 | |
| US62/022,639 | 2014-07-09 | ||
| PCT/US2015/039397 WO2016007522A1 (en) | 2014-07-09 | 2015-07-07 | Methods and compositions to modulate hair growth |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021082226A Division JP2021119202A (ja) | 2014-07-09 | 2021-05-14 | 発毛を調節するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017525672A JP2017525672A (ja) | 2017-09-07 |
| JP2017525672A5 JP2017525672A5 (https=) | 2018-08-16 |
| JP6941052B2 true JP6941052B2 (ja) | 2021-09-29 |
Family
ID=55064772
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017500319A Active JP6941052B2 (ja) | 2014-07-09 | 2015-07-07 | 発毛を調節するための方法および組成物 |
| JP2021082226A Withdrawn JP2021119202A (ja) | 2014-07-09 | 2021-05-14 | 発毛を調節するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021082226A Withdrawn JP2021119202A (ja) | 2014-07-09 | 2021-05-14 | 発毛を調節するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10716808B2 (https=) |
| EP (2) | EP4052714A1 (https=) |
| JP (2) | JP6941052B2 (https=) |
| KR (1) | KR102251129B1 (https=) |
| CN (1) | CN106661547B (https=) |
| AU (2) | AU2015287978B2 (https=) |
| CA (1) | CA2954282C (https=) |
| ES (1) | ES2909875T3 (https=) |
| IL (1) | IL249696A0 (https=) |
| MX (1) | MX2017000374A (https=) |
| SG (2) | SG10202111888XA (https=) |
| WO (1) | WO2016007522A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015287978B2 (en) | 2014-07-09 | 2021-04-29 | Sanford-Burnham Medical Research Institute | Methods and compositions to modulate hair growth |
| FR3071512B1 (fr) * | 2017-09-28 | 2022-02-25 | Oreal | Signatures moleculaires de trois sous-populations de fibroblastes dermiques et equivalent de derme comprenant une de ces sous-populations |
| CN108324993B (zh) * | 2018-01-15 | 2020-11-03 | 朱剑虹 | 一种诱导毛发再生的干细胞复合体、其制备方法及应用 |
| WO2019215557A1 (en) * | 2018-05-07 | 2019-11-14 | Reelabs Pvt. Ltd. | The method of autologous primary hair follicles preparation in 3d culture |
| US11468490B2 (en) | 2019-01-11 | 2022-10-11 | The Gillette Company Llc | Method for providing a customized product recommendation |
| CN110531057B (zh) * | 2019-07-01 | 2020-11-20 | 启迪禾美生物科技(嘉兴)有限公司 | 高通量筛选护肤品用活性组合物的方法 |
| EP4419648A1 (en) * | 2021-10-20 | 2024-08-28 | dNovo Inc. | Transdifferentiation of non-dermal papilla cells to dermal papilla cells |
| CN117551600B (zh) * | 2024-01-04 | 2024-04-02 | 成都云测医学生物技术有限公司 | 一种促进诱导间充质干细胞分化为真皮乳头细胞的培养基及诱导方法 |
| KR20250174330A (ko) * | 2024-06-05 | 2025-12-12 | 주식회사 큐스템 | 모유두 세포 배양액 추출물을 포함하는 두피 모낭 신생 촉진용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030161815A1 (en) | 2002-02-12 | 2003-08-28 | Intercytex Limited | Cell delivery system |
| GB0605450D0 (en) * | 2006-03-17 | 2006-04-26 | Intercytex Ltd | Cell co-culture |
| US8017390B2 (en) * | 2007-07-20 | 2011-09-13 | Dongguk University Industry-Academic Cooperation Foundation | Method for the preparation of dermal papilla tissue employing mesenchymal stem cells |
| JP6469655B2 (ja) | 2013-05-03 | 2019-02-13 | ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド | 代用皮膚および毛包新生の方法 |
| JP6304818B2 (ja) * | 2014-04-21 | 2018-04-04 | 花王株式会社 | 皮膚由来多能性前駆細胞の作製方法 |
| AU2015287978B2 (en) | 2014-07-09 | 2021-04-29 | Sanford-Burnham Medical Research Institute | Methods and compositions to modulate hair growth |
-
2015
- 2015-07-07 AU AU2015287978A patent/AU2015287978B2/en not_active Ceased
- 2015-07-07 EP EP22154365.5A patent/EP4052714A1/en not_active Withdrawn
- 2015-07-07 MX MX2017000374A patent/MX2017000374A/es unknown
- 2015-07-07 WO PCT/US2015/039397 patent/WO2016007522A1/en not_active Ceased
- 2015-07-07 SG SG10202111888XA patent/SG10202111888XA/en unknown
- 2015-07-07 CN CN201580046441.8A patent/CN106661547B/zh active Active
- 2015-07-07 KR KR1020177003248A patent/KR102251129B1/ko not_active Expired - Fee Related
- 2015-07-07 CA CA2954282A patent/CA2954282C/en active Active
- 2015-07-07 ES ES15818144T patent/ES2909875T3/es active Active
- 2015-07-07 SG SG11201700095SA patent/SG11201700095SA/en unknown
- 2015-07-07 EP EP15818144.6A patent/EP3167047B1/en active Active
- 2015-07-07 US US15/320,529 patent/US10716808B2/en active Active
- 2015-07-07 JP JP2017500319A patent/JP6941052B2/ja active Active
-
2016
- 2016-12-21 IL IL249696A patent/IL249696A0/en unknown
-
2020
- 2020-05-22 US US16/882,142 patent/US11839629B2/en active Active
-
2021
- 2021-05-14 JP JP2021082226A patent/JP2021119202A/ja not_active Withdrawn
- 2021-07-29 AU AU2021209278A patent/AU2021209278B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN106661547B (zh) | 2021-03-30 |
| US11839629B2 (en) | 2023-12-12 |
| US20170182095A1 (en) | 2017-06-29 |
| US10716808B2 (en) | 2020-07-21 |
| SG10202111888XA (en) | 2021-11-29 |
| SG11201700095SA (en) | 2017-02-27 |
| CA2954282C (en) | 2023-04-04 |
| IL249696A0 (en) | 2017-02-28 |
| AU2021209278B2 (en) | 2023-09-07 |
| MX2017000374A (es) | 2017-08-25 |
| KR20170020724A (ko) | 2017-02-23 |
| EP3167047A4 (en) | 2018-04-25 |
| JP2017525672A (ja) | 2017-09-07 |
| BR112017000085A2 (pt) | 2017-10-31 |
| ES2909875T3 (es) | 2022-05-10 |
| AU2015287978A1 (en) | 2017-02-02 |
| US20200345772A1 (en) | 2020-11-05 |
| CN106661547A (zh) | 2017-05-10 |
| EP4052714A1 (en) | 2022-09-07 |
| AU2015287978B2 (en) | 2021-04-29 |
| CA2954282A1 (en) | 2016-01-14 |
| EP3167047B1 (en) | 2022-03-09 |
| AU2021209278A1 (en) | 2021-08-19 |
| WO2016007522A1 (en) | 2016-01-14 |
| EP3167047A1 (en) | 2017-05-17 |
| JP2021119202A (ja) | 2021-08-12 |
| KR102251129B1 (ko) | 2021-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6941052B2 (ja) | 発毛を調節するための方法および組成物 | |
| Yu et al. | Isolation of a novel population of multipotent adult stem cells from human hair follicles | |
| Hunt et al. | A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin | |
| Techawattanawisal et al. | Isolation of multipotent stem cells from adult rat periodontal ligament by neurosphere-forming culture system | |
| Yu et al. | Stem cells with neural crest characteristics derived from the bulge region of cultured human hair follicles | |
| Curchoe et al. | Early acquisition of neural crest competence during hESCs neuralization | |
| CN102186969A (zh) | 由人多能干细胞制备人皮肤替代品的方法 | |
| SG183097A1 (en) | Methods for preparing human melanocytes from human pluripotent stem cells | |
| Oh et al. | Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury | |
| Yoo et al. | Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication | |
| TW201504435A (zh) | 毛囊形成用組合物之品質管理方法 | |
| KR20230026952A (ko) | 전분화능 줄기세포 유래 상피 오가노이드의 제조방법 | |
| US20060281177A1 (en) | Method of isolating epidermal neural crest stem cells | |
| TW202340454A (zh) | 將誘導性多能幹細胞分化為視網膜色素上皮細胞之方法、視網膜色素上皮細胞以及使用該視網膜色素上皮細胞之方法 | |
| HK40080429A (en) | Methods and compositions to modulate hair growth | |
| WO2012004310A1 (en) | Adipose tissue model and preparation process | |
| BR112017000085B1 (pt) | Método para preparação de uma população de células papilares dérmicas induzidas | |
| Figiel-Dabrowska et al. | Neurogenic and neuroprotective potential of stem/stromal cells derived from adipose tissue. Cells. 2021; 10: 1475 | |
| HK1235430B (en) | Methods and compositions to modulate hair growth | |
| HK1235430A1 (en) | Methods and compositions to modulate hair growth | |
| Messat et al. | Transdifferentiation of Human Dental Pulp Mesenchymal Stem Cells into Spiral Ganglion-like Neurons | |
| Abreu | Strategies Towards the Recreation of a Hair Follicle Regenerative Microenvironment | |
| Emmerson | The in vitro plasticity of hair follicle dermal and mesenchymal stem cells | |
| Harris | Properties of Vibrissa follicle cells during follicle development and regeneration, and their interactions with embryonic stem cells. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170404 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170321 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180705 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180705 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190801 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191101 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191227 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200129 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200408 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200703 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201007 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210114 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210514 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20210514 |
|
| C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20210526 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20210702 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20210705 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210824 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210903 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6941052 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |